Prescription Drug Monitoring Act of 2024
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Prescription Drug Monitoring Act of 2024 is a Senate bill introduced in the 118th Congress aimed at addressing issues related to prescription drug monitoring. The bill was read twice and referred to the Committee on Health, Education, Labor, and Pensions but ultimately failed or expired without further legislative action. No official summary or full text is available, limiting detailed analysis of its provisions or objectives. The bill falls within the health policy area, suggesting a focus on regulating or improving prescription drug monitoring systems to potentially combat misuse or improve healthcare outcomes.
This bill sought to enhance prescription drug monitoring but did not advance beyond committee referral and expired without enactment.
- The bill was introduced in the Senate during the 118th Congress and referred to the Health, Education, Labor, and Pensions Committee.
- No official summary or full text is publicly available, restricting detailed understanding of the bill's specific measures.
- The bill is categorized under the health policy area, indicating its focus on prescription drug monitoring.
['Healthcare providers who rely on prescription drug monitoring data', 'Patients who may benefit from improved prescription oversight', 'Public health agencies involved in monitoring drug use and abuse']
['Lack of publicly available full text and summary limits transparency and understanding of implementation details', 'Unclear funding mechanisms or enforcement provisions due to missing bill text', 'Potential challenges in oversight and authority allocation cannot be assessed without detailed provisions']
The bill was introduced and referred to the Senate Committee on Health, Education, Labor, and Pensions but did not progress further and expired. This reflects the legislative process where many bills do not advance beyond committee referral. The absence of detailed public documentation limits insight into legislative debates or stakeholder positions.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential improvements in prescription drug monitoring could reduce prescription drug misuse if implemented.', 'Enhanced data sharing among healthcare providers and agencies might improve public health responses.', 'Failure to pass the bill may delay reforms or improvements in prescription drug monitoring systems.']
The lack of publicly available bill text and summary highlights a transparency gap that limits public and stakeholder understanding of the bill's content and implications. This absence complicates oversight and informed discussion about the bill's potential impact on health policy and prescription drug monitoring.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.